HOME > Overseas Activity

Overseas Activity

 Over many years, Kaken has been marketing a number of its original products under license or distributorship in overseas countries. Such out-licensed products include Mentax, Empynase, Sonifilan, and Fiblast.

 Mentax is an antifungal agent launched or approved in Asian countries and the U.S.A.

 Clenafin/Jublia is a topical agent for onychomycosis,launched in Japan,Canada,and the U.S.A.

 Fiblast is a spray formulation to treat skin ulcers such as bed-sore and burns. After obtaining marketing authorization, Daewoong distribute Fiblast in Korea.

Mentax ( Antifungal Drug )
COUNTRY COMPANY STATUS BRAND NAME
U.S.A. Bertek Launched Mentax
Schering-Plough HealthCare Products Launched Lotrimin Ultra(OTC)
Korea Yungjin Launched Mentax
Choongwae Shinyak Launched Butena
Israel Perrigo Launched Mentax
Taiwan Sinphar Launched Mentax
Jordan Hikma Launched Mentax
Clenafin
COUNTRY COMPANY STATUS BRAND NAME
U.S.A Valeant Launched Jublia
Copyright(C) Kaken Pharmaceutical Co.,Ltd. All Rights Reserved.
Kaken Pharmaceutical Co.,Ltd. HOME Site map Contact Japanese